Interwest Venture Management CO Glaukos Corp Transaction History

Interwest Venture Management CO

$20.6 Million
Q3 2023

A detailed history of Interwest Venture Management CO transactions in Glaukos Corp stock. As of the latest transaction made, Interwest Venture Management CO holds 16,347 shares of GKOS stock, worth $2.47 Million. This represents 5.96% of its overall portfolio holdings.

Number of Shares

16,347

Previous 16,347 -0.0%

Holding current value

$2.47 Million

Previous $1.16 Million 5.67%

% of portfolio

5.96%

Previous 4.75%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$46.84 - $58.49 $15.7 Million - $19.6 Million	-334,897 Reduced 95.35%	16,347 $870,000
Q2 2022 Aug 02, 2022	BUY	$34.86 - $63.77 $34,162 - $62,494	980 Added 0.28%	351,244 $16 Million
Q3 2021 Oct 19, 2021	BUY	$47.43 - $84.23 $184,977 - $328,497	3,900 Added 1.13%	350,264 $16.9 Million
Q1 2021 Apr 15, 2021	SELL	$70.43 - $97.42 $21.1 Million - $29.2 Million	-300,000 Reduced 46.41%	346,364 $29.1 Million
Q2 2020 Jul 23, 2020	SELL	$28.78 - $46.83 $10.6 Million - $17.2 Million	-367,000 Reduced 36.22%	646,364 $24.8 Million
Q4 2019 Jan 23, 2020	BUY	$54.18 - $65.64 $54.3 Million - $65.8 Million	1,002,013 Added 8827.53%	1,013,364 $55.2 Million
Q3 2019 Oct 15, 2019	BUY	$58.58 - $83.91 $196,594 - $281,601	3,356 Added 41.98%	11,351 $709,000
Q2 2019 Jul 29, 2019	BUY	$63.59 - $78.71 $294,612 - $364,663	4,633 Added 137.8%	7,995 $602,000
Q3 2018 Oct 04, 2018	SELL	$38.13 - $68.37 $38.7 Million - $69.4 Million	-1,015,000 Reduced 99.67%	3,362 $218,000
Q3 2017 Oct 11, 2017	BUY	$31.26 - $42.03 $31.8 Million - $42.8 Million	1,018,362	1,018,362 $33.6 Million

Others Institutions Holding GKOS

# of Institutions

341

Shares Held

46.8M

Call Options Held

132K

Put Options Held

188K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.18B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Interwest Venture Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Interwest Venture Management CO with notifications on news.

Account

Interwest Venture Management CO Glaukos Corp Transaction History